Donald Trump raged against the pharmaceutical industry as a candidate. He accused drug companies of “getting away with murder” as president-elect. But he hasn’t done too much to tackle prices as president — yet.
Trump has occasionally criticized high drug prices, but he hasn’t taken any executive actions to lower them. A wave of companies hiked prices at the turn of the new year, keeping the increases around 10 percent, a move Regeneron CEO Leonard Schleifer told CNBC worries him will prompt regulation.
